The Lancet | GenomeWeb

The Lancet

The study, the second major clinical validation of the test, was published in the same week that Cepheid reported strong first-quarter results and several financial analysts raised their earnings estimates for the company.

Findings in a NEJM study this week challenged previously reported data that alleles in the CYP2C19 gene can limit how certain carriers of the polymorphisms respond to Plavix.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.